Lepu Biopharma's $1.6 Billion ADC Licensing Agreement with ArriVent Biopharma

Retrieved on: 2025-01-27 00:07:38

Tags for this article:

Click the tags to see associated articles and topics

Lepu Biopharma's $1.6 Billion ADC Licensing Agreement with ArriVent Biopharma. View article details on hiswai:

Excerpt

Ropes & Gray represented Lepu Biopharma in the transaction.Shanghai-based Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) announced an exclusive ...

Article found on: globallegalchronicle.com